$5.80
-0.16-2.68%
In chiusura: -
$6.00
0.203.45%
After hour: Oct 31, 5:22 PM EDT
Comments
Loading...
Attività di insider trading
Tieni traccia delle ultime attività di insider trading Karyopharm Therapeutics. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni Karyopharm Therapeutics.
Cos'è l'attività interna?
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
Cosa stanno facendo gli Karyopharm Therapeutics Inc addetti ai lavori?
Gli addetti ai lavori non hanno segnalato acquisti/vendite negli ultimi 30 giorni.
Notevoli acquisti e vendite recenti di insider
- Il giorno settembre 4, 2025, Kristin Abate, l'azienda CHIEF ACCOUNTING OFFICER sold 12 condivisioni per $6.78 ciascuna.
- Il giorno ottobre 3, 2025, Kristin Abate, l'azienda CHIEF ACCOUNTING OFFICER sold 362 condivisioni per $6.3 ciascuna.
Statistiche sulla proprietà per Karyopharm Therapeutics Inc
Numero di azioni emesse
15.927M
Azioni possedute dagli insider
3.082M
Percentuale posseduta dagli Insider
35.5%
Azioni possedute dagli investitori istituzionali
1.966M
Percentuale posseduta dagli investitori istituzionali
11.1%
Oct 03, 2025 | CHIEF ACCOUNTING OFFICER | -362.00 | $6.30 | -$2.28K | SELL | -3.48% | 10.05K | Oct 01 | ||
Sep 16, 2025 | PRESIDENT AND CEO | 1.54K | $6.43 | -$8.08K | GRANT | 1.87% | 84.05K | Sep 12 - Sep 15 | ||
Sep 16, 2025 | SVP, GENERAL COUNSEL&SECRETARY | 378.00 | $6.43 | -$1.50K | GRANT | 1.80% | 21.43K | Sep 12 - Sep 15 | ||
Sep 16, 2025 | EVP, CHIEF DEVELOPMENT OFFICER | 487.00 | $6.43 | -$2.58K | GRANT | 1.79% | 27.71K | Sep 12 - Sep 15 | ||
Sep 16, 2025 | EVP & CHIEF MEDICAL OFFICER | 537.00 | $6.43 | -$2.62K | GRANT | 1.86% | 29.39K | Sep 12 - Sep 15 | ||
Sep 16, 2025 | EVP & CHIEF COMMERCIAL OFFICER | 620.00 | $6.43 | -$2.09K | GRANT | 1.76% | 35.86K | Sep 12 - Sep 15 | ||
Sep 16, 2025 | CHIEF ACCOUNTING OFFICER | 23.00 | $6.43 | -$147.89 | GRANT | 0.22% | 10.41K | Sep 12 - Sep 15 | ||
Sep 04, 2025 | CHIEF ACCOUNTING OFFICER | -12.00 | $6.78 | -$81.36 | SELL | -0.13% | 9.46K | Sep 03 | ||
Jul 30, 2025 | EVP, CHIEF DEVELOPMENT OFFICER | -191.00 | $4.37 | -$834.67 | SELL | -0.70% | 27.22K | Jul 29 | ||
Jul 23, 2025 | CHIEF ACCOUNTING OFFICER | -238.00 | $4.00 | -$952.00 | SELL | -2.45% | 9.47K | Jul 22 | ||
May 07, 2025 | PRESIDENT AND CEO | -236.00 | $7.12 | -$1.68K | SELL | -0.29% | 82.50K | May 06 | ||
Apr 24, 2025 | EVP & CHIEF MEDICAL OFFICER | -419.00 | $6.17 | -$2.59K | SELL | -1.43% | 28.85K | Apr 23 | ||
Apr 07, 2025 | PRESIDENT AND CEO | -245.00 | $3.74 | -$916.30 | SELL | -0.30% | 82.74K | Apr 04 | ||
Mar 06, 2025 | EVP & CHIEF COMMERCIAL OFFICER | -3.44K | $6.29 | -$21.67K | SELL | -9.12% | 34.31K | Mar 04 | ||
Mar 06, 2025 | PRESIDENT AND CEO | -11.69K | $6.29 | -$73.56K | SELL | -12.35% | 82.98K | Mar 04 | ||
Mar 06, 2025 | EVP & CHIEF MEDICAL OFFICER | -3.59K | $6.29 | -$22.56K | SELL | -10.92% | 29.27K | Mar 04 | ||
Mar 06, 2025 | EVP, CHIEF DEVELOPMENT OFFICER | -3.55K | $6.29 | -$22.32K | SELL | -11.46% | 27.41K | Mar 04 | ||
Mar 06, 2025 | CHIEF ACCOUNTING OFFICER | -571.00 | $6.29 | -$3.59K | SELL | -5.55% | 9.71K | Mar 04 | ||
Mar 06, 2025 | SVP, GENERAL COUNSEL&SECRETARY | -2.79K | $6.29 | -$17.57K | SELL | -11.72% | 21.05K | Mar 04 | ||
Feb 19, 2025 | EVP, CHIEF DEVELOPMENT OFFICER | -5.91K | $0.63 | -$3.73K | SELL | -1.81% | 320.71K | Feb 18 | ||
Feb 05, 2025 | PRESIDENT AND CEO | -4.10K | $0.65 | -$2.66K | SELL | -0.36% | 1.12M | Feb 04 | ||
Jan 07, 2025 | PRESIDENT AND CEO | -4.05K | $0.78 | -$3.18K | SELL | -0.36% | 1.12M | Jan 06 | ||
Dec 05, 2024 | PRESIDENT AND CEO | -3.62K | $0.81 | -$2.93K | SELL | -0.32% | 1.13M | Dec 04 | ||
Nov 06, 2024 | PRESIDENT AND CEO | -3.67K | $0.91 | -$3.35K | SELL | -0.32% | 1.13M | Nov 05 | ||
Oct 07, 2024 | PRESIDENT AND CEO | -3.61K | $0.88 | -$3.17K | SELL | -0.32% | 1.14M | Oct 04 | ||
Sep 05, 2024 | SVP, GENERAL COUNSEL&SECRETARY | -3.97K | $0.72 | -$2.87K | SELL | -1.43% | 273.88K | Sep 04 | ||
Sep 05, 2024 | PRESIDENT AND CEO | -3.67K | $0.72 | -$2.65K | SELL | -0.32% | 1.14M | Sep 04 | ||
Sep 05, 2024 | EVP, CFO & TREASURER | -7.05K | $0.72 | -$5.09K | SELL | -1.77% | 391.05K | Sep 04 | ||
Sep 05, 2024 | EVP & CHIEF COMMERCIAL OFFICER | -5.36K | $0.72 | -$3.87K | SELL | -1.31% | 404.05K | Sep 04 | ||
Aug 08, 2024 | PRESIDENT AND CEO | -3.61K | $0.93 | -$3.36K | SELL | -0.31% | 1.14M | Aug 06 | ||
Jul 31, 2024 | EVP, CHIEF DEVELOPMENT OFFICER | -2.88K | $1.06 | -$3.06K | SELL | -0.87% | 326.63K | Jul 30 | ||
Jul 09, 2024 | PRESIDENT AND CEO | -3.62K | $0.85 | -$3.08K | SELL | -0.31% | 1.15M | Jul 05 | ||
Jun 07, 2024 | — | -818.04K | $0.96 | -$785.03K | SELL | -100.00% | 0.00 | Jun 05 - Jun 07 | ||
Jun 06, 2024 | EVP, CFO & TREASURER | -652.00 | $0.99 | -$645.48 | SELL | -0.16% | 398.10K | Jun 04 | ||
Jun 06, 2024 | PRESIDENT AND CEO | -3.59K | $0.99 | -$3.56K | SELL | -0.31% | 1.15M | Jun 04 | ||
Jun 04, 2024 | — | -906.18K | $0.97 | -$880.69K | SELL | -99.13% | 7.91K | May 31 - Jun 04 | ||
May 07, 2024 | PRESIDENT AND CEO | -3.58K | $1.13 | -$4.04K | SELL | -0.31% | 1.15M | May 06 | ||
Apr 23, 2024 | EVP & CHIEF MEDICAL OFFICER | -6.79K | $1.17 | -$7.94K | SELL | -1.94% | 342.93K | Apr 22 | ||
Apr 05, 2024 | PRESIDENT AND CEO | -3.56K | $1.29 | -$4.60K | SELL | -0.31% | 1.16M | Apr 04 | ||
Mar 06, 2024 | PRESIDENT AND CEO | -3.57K | $1.30 | -$4.64K | SELL | -0.31% | 1.16M | Mar 05 | ||
Mar 04, 2024 | EVP & CHIEF MEDICAL OFFICER | -21.64K | $1.18 | -$25.49K | SELL | -5.83% | 349.72K | Feb 29 - Mar 01 | ||
Mar 04, 2024 | EVP, CHIEF DEVELOPMENT OFFICER | -22.47K | $1.18 | -$26.47K | SELL | -6.38% | 329.51K | Feb 29 - Mar 01 | ||
Mar 04, 2024 | EVP, CFO & TREASURER | -33.85K | $1.18 | -$39.79K | SELL | -7.82% | 398.76K | Feb 29 - Mar 01 | ||
Mar 04, 2024 | SVP, GENERAL COUNSEL&SECRETARY | -20.55K | $1.18 | -$24.15K | SELL | -6.89% | 277.85K | Feb 29 - Mar 01 | ||
Mar 04, 2024 | EVP & CHIEF COMMERCIAL OFFICER | -26.95K | $1.18 | -$31.68K | SELL | -6.41% | 393.51K | Feb 29 - Mar 01 | ||
Mar 04, 2024 | PRESIDENT AND CEO | -99.84K | $1.18 | -$117.40K | SELL | -7.90% | 1.16M | Feb 29 - Mar 01 | ||
Feb 29, 2024 | EVP, CFO & TREASURER | 185.66K | $1.32 | -$3.37K | GRANT | 75.18% | 432.61K | Feb 27 - Feb 28 | ||
Feb 20, 2024 | EVP, CHIEF DEVELOPMENT OFFICER | -5.85K | $1.33 | -$7.78K | SELL | -3.45% | 163.77K | Feb 15 | ||
Feb 08, 2024 | EVP, CFO & TREASURER | -4.21K | $1.59 | -$6.67K | SELL | -1.67% | 246.94K | Feb 06 | ||
Feb 08, 2024 | PRESIDENT AND CEO | -4.01K | $1.59 | -$6.37K | SELL | -0.49% | 821.45K | Feb 06 | ||
Jan 08, 2024 | PRESIDENT AND CEO | -4.11K | $0.82 | -$3.37K | SELL | -0.52% | 783.47K | Jan 04 | ||
Dec 05, 2023 | PRESIDENT AND CEO | -3.62K | $0.79 | -$2.86K | SELL | -0.46% | 787.58K | Dec 04 | ||
Nov 07, 2023 | PRESIDENT AND CEO | -3.61K | $0.92 | -$3.32K | SELL | -0.45% | 791.20K | Nov 06 | ||
Oct 05, 2023 | PRESIDENT AND CEO | -3.59K | $1.27 | -$4.56K | SELL | -0.45% | 794.81K | Oct 04 | ||
Sep 12, 2023 | — | 41.14K | $1.22 | $49.99K | BUY | 1028.50% | 45.14K | Sep 12 | ||
Sep 06, 2023 | PRESIDENT AND CEO | -3.62K | $1.33 | -$4.82K | SELL | -0.45% | 798.40K | Sep 05 | ||
Sep 05, 2023 | EVP, CFO & TREASURER | -6.91K | $1.33 | -$9.20K | SELL | -2.82% | 237.82K | Sep 01 | ||
Sep 05, 2023 | SVP, GENERAL COUNSEL&SECRETARY | -3.89K | $1.33 | -$5.18K | SELL | -2.66% | 142.23K | Sep 01 | ||
Sep 05, 2023 | EVP & CHIEF COMMERCIAL OFFICER | -7.42K | $1.33 | -$9.87K | SELL | -3.51% | 204.09K | Sep 01 | ||
Aug 08, 2023 | PRESIDENT AND CEO | -3.72K | $1.72 | -$6.40K | SELL | -0.46% | 802.02K | Aug 07 | ||
Aug 01, 2023 | EVP, CHIEF DEVELOPMENT OFFICER | -2.85K | $1.70 | -$4.84K | SELL | -1.79% | 156.29K | Jul 28 | ||
Jul 06, 2023 | PRESIDENT AND CEO | -3.54K | $1.72 | -$6.09K | SELL | -0.44% | 805.74K | Jul 05 | ||
Jun 12, 2023 | EVP & CHIEF COMMERCIAL OFFICER | -1.84K | $2.35 | -$4.32K | SELL | -0.86% | 211.50K | Jun 08 | ||
Jun 07, 2023 | PRESIDENT AND CEO | -3.54K | $2.24 | -$7.92K | SELL | -0.44% | 809.28K | Jun 05 | ||
Jun 05, 2023 | EVP, CFO & TREASURER | -631.00 | $2.22 | -$1.40K | SELL | -0.26% | 244.73K | Jun 02 | ||
May 05, 2023 | PRESIDENT AND CEO | -3.81K | $3.35 | -$12.75K | SELL | -0.47% | 812.81K | May 04 | ||
Apr 24, 2023 | EVP & CHIEF MEDICAL OFFICER | -6.77K | $4.05 | -$27.42K | SELL | -4.10% | 158.23K | Apr 20 | ||
Apr 05, 2023 | PRESIDENT AND CEO | -3.50K | $3.97 | -$13.88K | SELL | -0.43% | 816.62K | Apr 04 | ||
Mar 07, 2023 | PRESIDENT AND CEO | -3.51K | $3.16 | -$11.08K | SELL | -0.43% | 820.12K | Mar 06 | ||
Mar 02, 2023 | SVP, CHIEF BUSINESS OFFICER | 53.64K | $3.03 | -$19.26K | GRANT | 71.84% | 128.31K | Feb 28 - Mar 01 | ||
Mar 02, 2023 | SVP, GENERAL COUNSEL&SECRETARY | 63.12K | $3.03 | -$20.83K | GRANT | 76.05% | 146.12K | Feb 28 - Mar 01 | ||
Mar 02, 2023 | EVP & CHIEF COMMERCIAL OFFICER | 88.76K | $3.03 | -$34.05K | GRANT | 72.80% | 210.69K | Feb 28 - Mar 01 | ||
Mar 02, 2023 | EVP, CFO & TREASURER | 83.80K | $3.03 | -$33.94K | GRANT | 51.86% | 245.36K | Feb 28 - Mar 01 | ||
Mar 02, 2023 | PRESIDENT AND CEO | 218.97K | $3.03 | -$100.06K | GRANT | 36.21% | 823.62K | Feb 28 - Mar 01 | ||
Mar 01, 2023 | EVP, CFO & TREASURER | -2.80K | $3.04 | -$8.51K | SELL | -1.70% | 161.57K | Feb 27 | ||
Feb 17, 2023 | EVP, CHIEF DEVELOPMENT OFFICER | -5.87K | $3.19 | -$18.72K | SELL | -8.38% | 64.13K | Feb 15 | ||
Feb 08, 2023 | EVP, CFO & TREASURER | -4.14K | $3.40 | -$14.08K | SELL | -2.46% | 164.37K | Feb 06 | ||
Feb 08, 2023 | PRESIDENT AND CEO | -3.95K | $3.40 | -$13.43K | SELL | -0.65% | 604.65K | Feb 06 | ||
Jan 05, 2023 | PRESIDENT AND CEO | -3.92K | $3.27 | -$12.82K | SELL | -0.64% | 608.61K | Jan 04 | ||
Dec 06, 2022 | PRESIDENT AND CEO | -3.49K | $5.17 | -$18.04K | SELL | -0.57% | 612.53K | Dec 05 | ||
Nov 08, 2022 | PRESIDENT AND CEO | -3.49K | $4.54 | -$15.86K | SELL | -0.56% | 616.02K | Nov 04 | ||
Oct 05, 2022 | PRESIDENT AND CEO | -3.49K | $5.87 | -$20.47K | SELL | -0.56% | 619.51K | Oct 04 | ||
Sep 09, 2022 | PRESIDENT AND CEO | -3.48K | $5.23 | -$18.20K | SELL | -0.56% | 623.00K | Sep 08 | ||
Aug 05, 2022 | PRESIDENT AND CEO | -2.31K | $4.48 | -$10.37K | SELL | -0.37% | 626.48K | Aug 04 | ||
Jul 11, 2022 | PRESIDENT AND CEO | -2.12K | $5.18 | -$10.95K | SELL | -0.34% | 628.79K | Jul 08 | ||
Jun 14, 2022 | CHIEF COMMERCIAL OFFICER | -1.55K | $5.21 | -$8.07K | SELL | -1.70% | 89.95K | Jun 13 | ||
Jun 10, 2022 | DIRECTOR | -538.78K | $6.38 | -$3.43M | SELL | -97.00% | 16.67K | Jun 08 - Jun 10 | ||
Jun 08, 2022 | PRESIDENT AND CEO | -2.54K | $5.76 | -$14.64K | SELL | -0.40% | 630.91K | Jun 07 | ||
Jun 06, 2022 | EVP, CFO, TREASURER | -601.00 | $6.04 | -$3.63K | SELL | -0.43% | 138.51K | Jun 03 | ||
Mar 02, 2022 | EVP, CHIEF DEV. OFFICER | 66.59K | $10.24 | -$17.03K | GRANT | 65.47% | 168.29K | Feb 28 | ||
Mar 02, 2022 | EVP, CFO & TREASURER | 85.80K | $10.24 | -$24.55K | GRANT | 160.96% | 139.11K | Feb 28 | ||
Mar 02, 2022 | CHIEF SCIENTIFIC OFFICER | 8.55K | $10.24 | -$127.48K | GRANT | 1.21% | 713.76K | Feb 28 | ||
Mar 02, 2022 | DIRECTOR | 8.55K | $10.24 | -$127.48K | GRANT | 0.96% | 898.13K | Feb 28 | ||
Feb 22, 2022 | EVP, CHIEF MEDICAL OFFICER | -1.31K | $12.12 | -$15.83K | SELL | -1.00% | 129.45K | Feb 17 | ||
Feb 22, 2022 | EVP, CHIEF DEV. OFFICER | -2.93K | $12.12 | -$35.51K | SELL | -2.80% | 101.70K | Feb 17 | ||
Feb 22, 2022 | CHIEF SCIENTIFIC OFFICER | -18.17K | $12.12 | -$220.25K | SELL | -2.53% | 698.98K | Feb 17 | ||
Feb 22, 2022 | DIRECTOR | -18.17K | $12.12 | -$220.25K | SELL | -1.97% | 904.36K | Feb 17 | ||
Feb 09, 2022 | EVP, CHIEF MEDICAL OFFICER | -1.70K | $9.86 | -$16.80K | SELL | -1.29% | 130.76K | Feb 07 | ||
Feb 09, 2022 | EVP, CHIEF DEV. OFFICER | -1.99K | $9.86 | -$19.64K | SELL | -1.87% | 104.63K | Feb 07 | ||
Feb 09, 2022 | EVP, CFO & TREASURER | -3.95K | $9.86 | -$38.93K | SELL | -6.89% | 53.31K | Feb 07 | ||
Feb 09, 2022 | DIRECTOR | -13.47K | $9.86 | -$132.85K | SELL | -1.45% | 913.45K | Feb 07 | ||
Feb 09, 2022 | CHIEF SCIENTIFIC OFFICER | -13.47K | $9.86 | -$132.85K | SELL | -1.87% | 708.06K | Feb 07 | ||
Dec 03, 2021 | SVP, CHIEF BUSINESS OFFICER | -499.00 | $6.69 | -$3.34K | SELL | -13.15% | 3.30K | Dec 02 | ||
Jun 03, 2021 | SVP, CHIEF BUSINESS OFFICER | -528.00 | $9.29 | -$4.91K | SELL | -17.60% | 2.47K | Jun 02 | ||
May 11, 2021 | EVP, CHIEF MEDICAL OFFICER | 23.25K | $8.60 | $199.99K | BUY | 21.42% | 131.80K | May 07 | ||
May 10, 2021 | DIRECTOR | 4.00K | $7.82 | $31.28K | BUY | ∞ | 4.00K | May 06 | ||
Mar 23, 2021 | PRESIDENT & CSO | -4.00K | $12.39 | -$49.55K | SELL | -0.24% | 1.63M | Mar 18 | ||
Mar 23, 2021 | CHIEF EXECUTIVE OFFICER | -4.00K | $12.39 | -$49.55K | SELL | -0.24% | 1.63M | Mar 18 | ||
Feb 22, 2021 | EVP, CHIEF MEDICAL OFFICER | -1.19K | $14.83 | -$17.59K | SELL | -2.24% | 51.79K | Feb 18 | ||
Feb 22, 2021 | EVP, CHIEF DEV. OFFICER | -2.89K | $14.83 | -$42.82K | SELL | -5.89% | 46.13K | Feb 18 | ||
Feb 22, 2021 | PRESIDENT & CSO | -18.99K | $14.83 | -$281.64K | SELL | -3.20% | 575.13K | Feb 18 | ||
Feb 22, 2021 | CHIEF EXECUTIVE OFFICER | -18.99K | $14.83 | -$281.64K | SELL | -2.39% | 776.45K | Feb 18 | ||
Feb 17, 2021 | EVP, CHIEF REG. AFFAIRS | -2.05K | $15.52 | -$31.75K | SELL | -33.06% | 4.14K | Feb 11 | ||
Feb 17, 2021 | EVP, CHIEF MEDICAL OFFICER | 3.10K | $15.52 | -$27.13K | SELL-OPTIONS | 6.22% | 52.98K | Feb 11 - Feb 15 | ||
Feb 17, 2021 | EVP, CHIEF DEV. OFFICER | 7.63K | $15.52 | -$31.75K | SELL-OPTIONS | 18.43% | 49.01K | Feb 11 - Feb 15 | ||
Feb 17, 2021 | SVP, CFO & TREASURER | -2.86K | $15.52 | -$44.35K | SELL | -35.07% | 5.29K | Feb 11 | ||
Feb 17, 2021 | PRESIDENT & CSO | 30.36K | $15.52 | -$205.52K | SELL-OPTIONS | 5.48% | 584.62K | Feb 11 - Feb 15 | ||
Feb 17, 2021 | CHIEF EXECUTIVE OFFICER | 30.36K | $15.52 | -$205.52K | SELL-OPTIONS | 4.02% | 785.95K | Feb 11 - Feb 15 | ||
Dec 22, 2020 | — | 0.00 | $11.71 | -$62.85K | OPTION EXERCISE | 0.00% | 0.00 | Dec 18 | ||
Dec 08, 2020 | — | 0.00 | $10.75 | -$212.78K | OPTION EXERCISE | 0.00% | 0.00 | Dec 07 | ||
Dec 03, 2020 | EVP, CBO, GC & SECRETARY | 0.00 | $13.98 | -$973.48K | SELL-OPTIONS | 0.00% | 4.52K | Dec 01 | ||
Nov 04, 2020 | — | 539.00 | $15.58 | -$3.52K | OPTION EXERCISE | ∞ | 539.00 | Oct 28 - Oct 30 | ||
Nov 04, 2020 | EVP, CHIEF MEDICAL OFFICER | 1.82K | $19.46 | -$11.46K | SELL-OPTIONS | 4.41% | 43.23K | Jul 11 - Jul 15 | ||
Nov 04, 2020 | EVP, CBO, GC & SECRETARY | -772.00 | $14.92 | -$11.52K | SELL | -14.58% | 4.52K | Nov 02 |
FAQ
L'insider trading è legale?
L'insider trading è legale a condizione che gli insider segnalino le loro operazioni alla SEC. Il trading illegale di titoli si verifica quando l'insider viola un dovere fiduciario o non segnala le sue operazioni.
Quali sono alcuni esempi di manipolazione del mercato?
L'insider trading, gli schemi di pump and dump, il front running e i wash trade sono tutti esempi di manipolazione del mercato. Gli investitori che seguono i movimenti delle attività degli insider dovrebbero riflettere attentamente sul motivo per cui questi insider stanno negoziando le loro azioni prima di procedere.
Sfoglia insider trading su tutte le azioni.